Rating of Debt Securities. The Company has no debt securities or preferred stock that is rated by any “nationally recognized statistical rating organization” (as that term is defined by the Commission for purposes of Rule 436(g)(2) under the 1933 Act).
Appears in 23 contracts
Samples: Underwriting Agreement (Exagen Inc.), Underwriting Agreement (Exagen Inc.), Underwriting Agreement
Rating of Debt Securities. The Company has no debt securities or preferred stock that is are rated by any “nationally recognized statistical rating organization” (as that term is defined by the Commission for purposes of Rule 436(g)(2) under the 1933 Act).
Appears in 3 contracts
Samples: Underwriting Agreement (INVO Bioscience, Inc.), Underwriting Agreement (INVO Bioscience, Inc.), INVO Bioscience, Inc.
Rating of Debt Securities. The Company has no debt securities or preferred stock that is rated by any “nationally recognized statistical rating organization” (as that term is defined by in Section 3(a)(62) of the Commission for purposes of Rule 436(g)(2) under the 1933 1934 Act).
Appears in 1 contract
Rating of Debt Securities. The Company has no debt securities or preferred stock that is rated by any “nationally recognized statistical rating organization” (as that term is defined by the Commission for purposes of Rule 436(g)(2) under of the 1933 Securities Act).
Appears in 1 contract
Samples: Underwriting Agreement (HTG Molecular Diagnostics, Inc)
Rating of Debt Securities. The Company has no debt securities or preferred stock that is rated by any “nationally recognized statistical rating organization” (as that term is defined by the Commission for purposes of Rule 436(g)(2) under of the 1933 ActAct Regulations).
Appears in 1 contract
Samples: Underwriting Agreement (HTG Molecular Diagnostics, Inc)
